IAPP and Parkinson disease: Researchers have found that IAPP and α-synuclein cross-interact in the two diseases, and IAPP in patients with T2DM can promote α-synuclein aggregation, which leads to the occurrence of PD (Horvath and Wittung-Stafshede, 2016).